Open AccessMalignant peritoneal mesothelioma. Is there a new treatment?
Author(s) -
Kakil Ibrahim Rasul,
Rachel Kerr
Publication year - 2009
Publication title -
rare tumors
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.285
H-Index - 15
eISSN - 2036-3613
pISSN - 2036-3605
DOI - 10.4081/rt.2009.e49
Subject(s) - medicine , bevacizumab , mesothelioma , vascular endothelial growth factor , vegf receptors , peritoneal mesothelioma , chemotherapy , oncology , pathology
The authors report a novel, alternative approach to treat malignant peritoneal mesothelioma (MPeM) targeting, vascular endothelial growth factor (VEGF) using anti-VEGF (bevacizumab) chemotherapy combination
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom